ZIPRASIDONE-INDUCED OCULOGYRIC CRISIS

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 42, Issue 9, 2003, Pages 1013-1014

  Ramos, Amaya E ^a   Shytle, R Douglas ^a   Silver, Archie A ^a   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; THIAZOLE DERIVATIVE; ZIPRASIDONE;

CASE REPORT; CHEMICALLY INDUCED DISORDER; CHILD; DYSTONIA; EYE MOVEMENT DISORDER; HUMAN; MALE; MENTAL DISEASE; NOTE;

ANTIPSYCHOTIC AGENTS; CHILD; DYSTONIA; HUMANS; MALE; MENTAL DISORDERS; OCULAR MOTILITY DISORDERS; PIPERAZINES; THIAZOLES;

EID: 0141905025     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1097/01.CHI.0000070257.24125.91     Document Type: Letter

References (4)

1. Gerlach J, Peacock L (1995), New antipsychotics: the present status. Int Clin Psychopharmacol 10(suppl 3):39-48
2. Green WH (2001), Child & Adolescent Clinical Psychopharmacology, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, p 93
3. Seeger TF, Seymour PA, Schmidt AW et al. (1995), Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther 275:101-113
4. Zorn SH, Lebel LL, Schmidt AW et al. (1999), Pharmacological and neurochemical studies with the new antipsychotic ziprasidone. In:Interactive Monoaminergic Basis of Brain Disorders, Palomo T, Reninger R, Archer T, eds. Madrid: Editoral Sintesis, pp 377-393